Private limited company · Tromsø
NORDIC PHARMA INC AS
ActiveManufacture of oils and fats (10.410)
The life line 2005–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 327.7m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
NORDIC PHARMA INC AS is a private limited company in Tromsø, founded in 2005, in the industry manufacture of oils and fats. The chief executive is Gorm Breimo, and the chair of the board is Astrid Opheim. In 2025 the company had NOK 327.7m in operating revenue and a net profit of NOK 44.4m.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 13 Nov 2026
- Number of employees 54 → 56
- Number of employees 55 → 54
- Number of employees 54 → 55
- Annual accounts filed 2024 → 2025
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
2 points
- NoteChanged auditor 23 Jan 2026
- OKEquity ratio 71.9%, above the industry median
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 327.7m in 2025
Revenue
NOK 327.7m
+13.5% from 2024
20232025
Operating profit
NOK 62.9m
+9.9% from 2024
20232025
Net profit
NOK 44.4m
+6.5% from 2024
20232025
Equity
NOK 374.6m
+13.5% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 11%
- Depreciation 8%
- Other operating costs 9%
- Not specified in the source 52%
- Left as operating result 19%
Of the net profit for 2025, NOK 44.4m stayed in the company. The rest, NOK 1, is an assumed dividend.
The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 71.9%
- NORDIC PHARMA INC AS, 2025
- Industry median, assumed: NOK 49.4m · 3.5% · 55.2% · +2.4%
Equity NOK 374.6m72% of the assets (NOK 521.0m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 25 companies in 10.410 Manufacture of oils and fats, not stated by the source.
Finances
§ 06 Accounts
21 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 327,727 | 288,844 | 264,923 | |
| Operating profit | 62,905 | 57,230 | 50,128 | |
| Profit before tax | 56,951 | 53,375 | 33,874 | |
| Net profit | 44,420 | 41,704 | 26,418 | |
| Total assets | 521,040 | 503,593 | 460,408 | |
| Equity | 374,593 | 330,173 | 288,469 | |
| Liabilities | 146,448 | 173,420 | 171,939 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 21 years →
Management and ownership
§ 07 Officers
4 officers now
- Gorm BreimoChief executive since 2020
- Astrid OpheimChair of the board since 2016
- CEDRA NORGE ASAuditor since 2026
- Ingrid Asta OpheimBoard member since 2025
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 4 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
Styrets leder og ett styremedlem i fellesskap.
May sign for the company:
Styrets leder og ett styremedlem i fellesskap.
Procuration: none registered.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 24 Aug 2026
Management and ownership
§ 09 Owners
None registered
No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.
Management and ownership
§ 10 Group
None registered
Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
4 connections
- Person
- Company
3 people link NORDIC PHARMA INC AS to 2 other companies: Astrid Opheim 1, Gorm Breimo 1 and Ingrid Asta Opheim 1.
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
38 since 2015
Events per year
20152026
Since 2015: 64 announcements and 9 register changes. Most happened in 2019 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 38 events →
Events and registers
§ 14 Notices
64, latest 11 Jul 2026
- Godkjente årsregnskap
- Revisor
- Revisor
Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 64 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 14 Jan 2006
- VATRegistered
- The Register of Business EnterprisesRegistered 14 Jan 2006
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Investere i- og utvikle næringsvirksomhet innen kosttilskudd, funksjonell mat og bioteknologi og marine ressurser, herunder delta i andre virksomheter gjennom aksjeeie eller på annen måte, og hva hermed står i forbindelse.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 10.410
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
6 questions
- Who is the chief executive of NORDIC PHARMA INC AS?
Gorm Breimo, since 2020. § 07 - What was the revenue in 2025?
NOK 327.7m in the company. § 06 - Who can sign for NORDIC PHARMA INC AS?
Styrets leder og ett styremedlem i fellesskap. § 08 - Who is the auditor?
CEDRA NORGE AS, from 23 Jan 2026. § 07 - Where is NORDIC PHARMA INC AS based?
Ropnesvegen 71, 9107 Kvaløya. - When was NORDIC PHARMA INC AS founded?
22 Nov 2005, registered in the Register of Business Enterprises 14 Jan 2006. § 16
The answers come from the sections linked to, with their sources.